PEDIATRICS Vol. 87 No. 1 January 1991, pp. 124-125
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by LEGGIADRO, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by LEGGIADRO, R. J.

Tetracycline for Rocky Mountain Spotted Fever

ROBERT J. LEGGIADRO MD1

1 Department of Pediatrics, Division of Infectious Diseases, University of Tennessee, Memphis, LeBonheur Children's Medical Center, Memphis, Tennessee 38103

To the Editor.—

I read with interest the editorial by Abramson and Givner on the use of tetracycline for suspected Rocky Mountain spotted fever (RMSF) in children younger than 9 years of age.1 Their discussion of the relative risks and benefits of tetracycline or chloramphenicol for RMSF and their conclusion that the contraindication of tetracycline (due to its risk of teeth-staining) in all children younger than 9 years old does not seem warranted is relevant to another tick-borne infection, tularemia.2